Author | Bruno Sangro, MD, PhD | OncLive

Author | Bruno Sangro, MD, PhD

Articles

Dr. Sangro on Updated Findings From the CheckMate-459 Trial in Advanced HCC

July 01, 2020

Video

Bruno Sangro, MD, PhD, discusses the updated findings from the phase 3 CheckMate-459 trial, which evaluated the use of nivolumab and sorafenib in the treatment of patients with advanced hepatocellular carcinoma.

Dr. Sangro on the Efficacy of Nivolumab in HCC

June 27, 2017

Article

Bruno Sangro, MD, PhD, head of Hepatology Unit, Internal Medicine Department, Clinica Universidad de Navarra, discusses the efficacy of nivolumab (Opdivo) in patients with hepatocellular carcinoma (HCC).

Dr. Sangro Discusses Safety Profile of Nivolumab in HCC

April 25, 2017

Video

Bruno Sangro, MD, PhD, head of Hepatology Unit, Internal Medicine Department, Clinica Universidad de Navarra, discusses the safety profile of nivolumab (Opdivo) in advanced hepatocellular carcinoma (HCC).

x